Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors.
A series of bicyclic pyrimidinone-based HCV NS3 protease inhibitors was synthesized via selective C8 position functionalization. Substituted phenylamides and phenylureas were preferred in the S2 binding pocket.